The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending ...
Share on Pinterest Lenacapavir is a twice-yearly injection to prevent HIV that could improve adherence rates compared to other PrEP medications. d3sign/Getty Images The WHO issued a global ...
A long-acting HIV prevention injection called lenacapavir is being hailed as one of the biggest breakthroughs in the fight against HIV in years, with researchers and global health organisations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results